Ranolazine (add‐on therapy) vs placebo
AMI incidence · patients with stable angina pectoris
Ranolazine (add‐on therapy) showed no clear difference in AMI incidence compared with placebo (low certainty).
1 finding from 1 review
- RR 0.4 [0.08, 2.07]2 studies · 1509 participantsLow